openPR Logo
Press release

Drug Eluting Balloon Market Insights,Forecast to 2024 | Koninklijke Philips N.V, Eurocor GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Bayer AG

02-12-2019 01:35 PM CET | Health & Medicine

Press release from: Infinium Global Research

Drug Eluting Balloon Market Insights,Forecast to 2024 |

The main objective of this report is to define, describe, and forecast the global “Drug Eluting Balloon” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges). It aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the market. The report attempts to forecast the market size for 5 major regions, namely, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It contains key vendor profiles and comprehensively analyzes their core competencies. The report also tracks and analyzes competitive developments, including partnerships, collaborations, acquisitions, new product developments, and R&D activities in the market. According to the report, the global drug eluting balloon market is projected to grow at a CAGR of 19% over the forecast period of 2018-2024.

Download a sample report: https://www.infiniumglobalresearch.com/reports/sample-request/2026

Drug-eluting balloons (DEB) are a conservative semi-compliant angioplasty balloon that is covered with an anti-proliferative drug. The (DE) balloon is inserted into the blocked artery and left for a few minutes. The drug is discharged into the vessel wall at the time of inflation of the balloon, and at minimal pressures with a minimal inflation time. Minor surgeries and open-heart surgeries can be threatening to life as they contain numerous difficulties. The surgeon adopts MI techniques over traditional techniques as they assure faster recovery, reduced hospital stays negligible obstacles and high accuracy. Drug-eluting balloons also play an important role in the treatment of coronary artery disease.

Growing geriatric population and rising incidence of peripheral artery diseases (PAD) worldwide are major factors driving the growth for drug-eluting balloon market. Coronary artery disease occurs when the arteries that supply blood to the heart muscle become narrow or hard owing to the accumulation of cholesterol and other resources on the inner walls. Hence, this results in deficient oxygen and blood flow and can lead to chest pain or heart attack. Coronary artery diseases also fail the heart muscle and can lead to heart failure and arrhythmias thus, growing prevalence for coronary artery diseases is another factor driving the growth of the market. Besides, Drug-eluting balloon is gaining acceptance amongst surgeons, as they are effective for the treatment of peripheral artery and coronary artery diseases. This balloon decreases the risk of stent failure is more effective in the treatment of superficial femoral artery (SFA). Increase in R&D activities supported by government policies is anticipated to generate an opportunity for coming years. On the other side, long-governing approval procedure, and major investment required owing to the high erosion rate in clinical trials are likely to hamper the market growth for drug-eluting balloon market.

Among the geographies, North America holds the significant share in drug-eluting balloon market. Owing to increasing awareness regarding therapeutic applications of drug-eluting balloons in coronary and peripheral artery diseases is driving the growth of the drug-eluting balloon market in North America region. Additionally, augmented investments by several foreign medical device companies have also pushed the growth of the drug-eluting balloons market in this region.

The report on global drug eluting balloon market covers segments such as product type, end-user, and coating technology. On the basis of product type, the sub-markets include peripheral drug eluting balloon, coronary drug eluting balloon, and others. On the basis of end-user, the sub-markets include cath labs, hospitals, ambulatory surgery centers, and others. On the basis of coating technology, the sub-markets include enduracoat, freepac, paccocath, transpax, and others.

Feel Free to Get in Touch for Discounts and Customized Details: https://www.infiniumglobalresearch.com/reports/request-discount/2026

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region, as it is the largest market in this region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.

The report provides profiles of the companies in the market such as Koninklijke Philips N.V, Eurocor GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Bayer AG, Terumo Corporation, Becton, Dickinson and Company, Cook Medical, Inc., and Medtronic Plc.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of drug eluting balloon market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

About Us

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Contact Us:

Infinium Global Research
Tel: +1-800-638-0796
Email: info@infiniumglobalresearch.com
Website: https://www.infiniumglobalresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Market Insights,Forecast to 2024 | Koninklijke Philips N.V, Eurocor GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Bayer AG here

News-ID: 1581062 • Views:

More Releases from Infinium Global Research

Global Aircraft Tyre Market Size Worth USD 2478.09 Million By 2030 | CAGR 5.47%: Infinium Global Research
Global Aircraft Tyre Market Size Worth USD 2478.09 Million By 2030 | CAGR 5.47%: …
Infinium Global Research, a prominent market research firm, has released an in-depth report providing a comprehensive analysis of the Global Aircraft Tyre Market. The report dives into segments and sub-segments, highlighting both global trends and regional insights that significantly impact this dynamic industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1058 Steady Market Growth The global aircraft tyre market, valued at USD 1634.41 million in 2022, is anticipated to surge to
Global Automotive Interior Leather Market to Hit USD 61.6 Billion, Globally By 2030 at 6.50% CAGR | Infinium Global Research
Global Automotive Interior Leather Market to Hit USD 61.6 Billion, Globally By 2 …
Infinium Global Research, a leading research firm, has published an extensive report providing a detailed analysis of the Global Automotive Interior Leather Market. The report offers comprehensive insights into segments and sub-segments, highlighting both global trends and regional dynamics shaping this thriving industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1266 Steady Market Growth The global automotive interior leather market, valued at USD 30.82 billion in 2022, is projected to skyrocket
Global Automatic Car Wash Market Growing at a CAGR of 4.01% to Reach USD 5.82 Billion By 2030 | Infinium Global Research
Global Automatic Car Wash Market Growing at a CAGR of 4.01% to Reach USD 5.82 Bi …
Infinium Global Research, a leading authority in market analysis, has released an extensive report offering a deep dive into the Global Automatic Car Wash Market. The report presents an in-depth analysis of segments and sub-segments, shedding light on both global trends and regional dynamics impacting this burgeoning industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1295 Robust Market Growth The automatic car wash market, valued at USD 4.04 billion
Global Automotive Logistics Market is Anticipated to Reach USD 363.03 Billion at a Robust CAGR of 5.51% Between 2023 to 2030 | Infinium Global Research
Global Automotive Logistics Market is Anticipated to Reach USD 363.03 Billion at …
Infinium Global Research, a leading market research firm, has released an expansive report offering an in-depth analysis of the Global Automotive Logistics Market. The report delves into crucial segments and sub-segments, shedding light on both global and regional dynamics impacting this intricate industry. The comprehensive study reveals the profound impact of drivers, restraints, and macro indicators on the automotive logistics market. Providing a comprehensive outlook, the report highlights evolving trends, forecasts,

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase